Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0360 Transporter Info | ||||
Gene Name | SLC43A1 | ||||
Transporter Name | L-type amino acid transporter 3 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Atypical teratoid rhabdoid tumor |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC43A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg07764959) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:1.31E-07; Z-score:-1.10E+00 | ||
Methylation in Case |
9.04E-01 (Median) | Methylation in Control | 9.30E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC43A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg08572535) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.35E+00 | Statistic Test | p-value:1.41E-07; Z-score:1.42E+00 | ||
Methylation in Case |
9.24E-01 (Median) | Methylation in Control | 6.84E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC43A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg00089550) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:1.67E-05; Z-score:6.62E-01 | ||
Methylation in Case |
8.65E-01 (Median) | Methylation in Control | 7.95E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC43A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg02680086) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.14E+00 | Statistic Test | p-value:2.03E-04; Z-score:-1.05E+00 | ||
Methylation in Case |
7.51E-01 (Median) | Methylation in Control | 8.56E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC43A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg04431596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.29E+00 | Statistic Test | p-value:7.45E-04; Z-score:-1.30E+00 | ||
Methylation in Case |
4.08E-01 (Median) | Methylation in Control | 5.28E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC43A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg09478995) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.15E+00 | Statistic Test | p-value:1.06E-02; Z-score:6.65E-01 | ||
Methylation in Case |
7.52E-01 (Median) | Methylation in Control | 6.54E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC43A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg10964211) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:1.95E-02; Z-score:6.04E-01 | ||
Methylation in Case |
8.60E-01 (Median) | Methylation in Control | 7.75E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC43A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg11376147) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.14E+00 | Statistic Test | p-value:2.19E-02; Z-score:5.34E-01 | ||
Methylation in Case |
4.22E-01 (Median) | Methylation in Control | 3.70E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC43A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg12619347) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:2.85E-02; Z-score:-4.23E-01 | ||
Methylation in Case |
8.29E-01 (Median) | Methylation in Control | 8.55E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC43A1 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
3'UTR (cg09888840) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.49E+00 | Statistic Test | p-value:1.49E-12; Z-score:-2.42E+00 | ||
Methylation in Case |
4.63E-01 (Median) | Methylation in Control | 6.90E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
17 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC43A1 in breast cancer | [ 2 ] | |||
Location |
5'UTR (cg08572535) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.23E+00 | Statistic Test | p-value:9.62E-06; Z-score:1.04E+00 | ||
Methylation in Case |
1.01E-01 (Median) | Methylation in Control | 8.19E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC43A1 in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg26624118) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.19E+00 | Statistic Test | p-value:2.86E-04; Z-score:8.08E-01 | ||
Methylation in Case |
8.80E-02 (Median) | Methylation in Control | 7.43E-02 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC43A1 in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg05375277) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.47E+00 | Statistic Test | p-value:1.93E-02; Z-score:5.56E-01 | ||
Methylation in Case |
9.34E-03 (Median) | Methylation in Control | 6.34E-03 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC43A1 in breast cancer | [ 2 ] | |||
Location |
TSS200 (cg14028489) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.44E+00 | Statistic Test | p-value:3.30E-02; Z-score:3.94E-01 | ||
Methylation in Case |
5.21E-03 (Median) | Methylation in Control | 3.62E-03 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC43A1 in breast cancer | [ 2 ] | |||
Location |
Body (cg23075364) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.64E+00 | Statistic Test | p-value:4.73E-25; Z-score:6.51E+00 | ||
Methylation in Case |
5.13E-01 (Median) | Methylation in Control | 1.94E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC43A1 in breast cancer | [ 2 ] | |||
Location |
Body (cg17330838) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.86E+00 | Statistic Test | p-value:5.92E-22; Z-score:4.03E+00 | ||
Methylation in Case |
5.80E-01 (Median) | Methylation in Control | 3.11E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC43A1 in breast cancer | [ 2 ] | |||
Location |
Body (cg02680086) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:3.10E+00 | Statistic Test | p-value:7.28E-21; Z-score:5.94E+00 | ||
Methylation in Case |
4.57E-01 (Median) | Methylation in Control | 1.48E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC43A1 in breast cancer | [ 2 ] | |||
Location |
Body (cg26418434) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.12E+00 | Statistic Test | p-value:9.07E-20; Z-score:4.05E+00 | ||
Methylation in Case |
4.46E-01 (Median) | Methylation in Control | 2.10E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC43A1 in breast cancer | [ 2 ] | |||
Location |
Body (cg00089550) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.60E+00 | Statistic Test | p-value:4.19E-19; Z-score:3.27E+00 | ||
Methylation in Case |
4.34E-01 (Median) | Methylation in Control | 2.71E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC43A1 in breast cancer | [ 2 ] | |||
Location |
Body (cg11376147) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.32E+00 | Statistic Test | p-value:8.78E-18; Z-score:-2.95E+00 | ||
Methylation in Case |
2.26E-01 (Median) | Methylation in Control | 2.97E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC43A1 in breast cancer | [ 2 ] | |||
Location |
Body (cg25284762) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.33E+00 | Statistic Test | p-value:2.82E-15; Z-score:4.14E+00 | ||
Methylation in Case |
6.10E-01 (Median) | Methylation in Control | 4.57E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC43A1 in breast cancer | [ 2 ] | |||
Location |
Body (cg12619347) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.25E+00 | Statistic Test | p-value:2.74E-11; Z-score:-2.83E+00 | ||
Methylation in Case |
4.87E-01 (Median) | Methylation in Control | 6.10E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
Methylation of SLC43A1 in breast cancer | [ 2 ] | |||
Location |
Body (cg27315497) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.24E+00 | Statistic Test | p-value:1.76E-07; Z-score:1.09E+00 | ||
Methylation in Case |
5.93E-01 (Median) | Methylation in Control | 4.79E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon14 |
Methylation of SLC43A1 in breast cancer | [ 2 ] | |||
Location |
Body (cg04431596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:5.43E-07; Z-score:-1.43E+00 | ||
Methylation in Case |
8.35E-01 (Median) | Methylation in Control | 8.93E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon15 |
Methylation of SLC43A1 in breast cancer | [ 2 ] | |||
Location |
Body (cg17559156) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.11E+00 | Statistic Test | p-value:6.87E-05; Z-score:-1.12E+00 | ||
Methylation in Case |
6.36E-01 (Median) | Methylation in Control | 7.05E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon16 |
Methylation of SLC43A1 in breast cancer | [ 2 ] | |||
Location |
Body (cg09478995) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:1.98E-02; Z-score:-4.50E-01 | ||
Methylation in Case |
6.54E-01 (Median) | Methylation in Control | 6.75E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon17 |
Methylation of SLC43A1 in breast cancer | [ 2 ] | |||
Location |
3'UTR (cg09888840) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:1.22E-03; Z-score:-8.75E-01 | ||
Methylation in Case |
7.77E-01 (Median) | Methylation in Control | 8.47E-01 (Median) | ||
Studied Phenotype |
Breast cancer[ ICD-11:2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
14 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC43A1 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
5'UTR (cg08572535) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.36E+00 | Statistic Test | p-value:3.67E-05; Z-score:1.88E+00 | ||
Methylation in Case |
7.50E-02 (Median) | Methylation in Control | 5.50E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC43A1 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
5'UTR (cg07764959) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.11E+00 | Statistic Test | p-value:6.94E-03; Z-score:5.63E-01 | ||
Methylation in Case |
2.08E-02 (Median) | Methylation in Control | 1.88E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC43A1 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
TSS1500 (cg26624118) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.28E+00 | Statistic Test | p-value:8.22E-03; Z-score:1.21E+00 | ||
Methylation in Case |
3.00E-02 (Median) | Methylation in Control | 2.35E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC43A1 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
TSS1500 (cg05375277) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:8.54E-03; Z-score:8.60E-01 | ||
Methylation in Case |
1.52E-02 (Median) | Methylation in Control | 1.38E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC43A1 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
TSS200 (cg02037518) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:9.32E-03; Z-score:6.75E-01 | ||
Methylation in Case |
1.75E-02 (Median) | Methylation in Control | 1.65E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC43A1 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
TSS200 (cg17057783) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:1.85E-02; Z-score:4.39E-01 | ||
Methylation in Case |
2.89E-02 (Median) | Methylation in Control | 2.66E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC43A1 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
TSS200 (cg23409370) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:4.02E-02; Z-score:2.17E-01 | ||
Methylation in Case |
2.52E-02 (Median) | Methylation in Control | 2.41E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC43A1 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
Body (cg25284762) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.28E+00 | Statistic Test | p-value:1.06E-09; Z-score:4.10E+00 | ||
Methylation in Case |
7.22E-01 (Median) | Methylation in Control | 5.66E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC43A1 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
Body (cg02680086) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.37E+00 | Statistic Test | p-value:1.19E-06; Z-score:1.70E+00 | ||
Methylation in Case |
1.76E-01 (Median) | Methylation in Control | 7.43E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC43A1 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
Body (cg23075364) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.04E+00 | Statistic Test | p-value:1.96E-06; Z-score:1.47E+00 | ||
Methylation in Case |
2.46E-01 (Median) | Methylation in Control | 1.21E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC43A1 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
Body (cg17330838) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.55E+00 | Statistic Test | p-value:3.80E-06; Z-score:1.50E+00 | ||
Methylation in Case |
3.56E-01 (Median) | Methylation in Control | 2.29E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC43A1 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
Body (cg00089550) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.40E+00 | Statistic Test | p-value:6.19E-06; Z-score:1.44E+00 | ||
Methylation in Case |
3.82E-01 (Median) | Methylation in Control | 2.74E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
Methylation of SLC43A1 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
Body (cg27315497) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:3.31E-02; Z-score:1.28E+00 | ||
Methylation in Case |
6.86E-01 (Median) | Methylation in Control | 6.45E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon14 |
Methylation of SLC43A1 in clear cell renal cell carcinoma | [ 3 ] | |||
Location |
3'UTR (cg09888840) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:3.02E-05; Z-score:-1.58E+00 | ||
Methylation in Case |
9.27E-01 (Median) | Methylation in Control | 9.55E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma[ ICD-11:2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC43A1 in colon adenocarcinoma | [ 4 ] | |||
Location |
5'UTR (cg00162231) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.43E+00 | Statistic Test | p-value:1.46E-06; Z-score:1.81E+00 | ||
Methylation in Case |
5.81E-01 (Median) | Methylation in Control | 4.07E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC43A1 in colon adenocarcinoma | [ 4 ] | |||
Location |
5'UTR (cg15374686) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.19E+00 | Statistic Test | p-value:1.08E-03; Z-score:1.86E+00 | ||
Methylation in Case |
6.23E-01 (Median) | Methylation in Control | 5.24E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC43A1 in colon adenocarcinoma | [ 4 ] | |||
Location |
5'UTR (cg18003231) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.04E+00 | Statistic Test | p-value:1.29E-03; Z-score:5.10E-01 | ||
Methylation in Case |
8.89E-01 (Median) | Methylation in Control | 8.58E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC43A1 in colon adenocarcinoma | [ 4 ] | |||
Location |
TSS1500 (cg05331214) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.69E+00 | Statistic Test | p-value:7.16E-08; Z-score:-8.23E+00 | ||
Methylation in Case |
4.00E-01 (Median) | Methylation in Control | 6.78E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC43A1 in colon adenocarcinoma | [ 4 ] | |||
Location |
TSS1500 (cg09456905) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.23E+00 | Statistic Test | p-value:2.17E-06; Z-score:-2.27E+00 | ||
Methylation in Case |
5.06E-01 (Median) | Methylation in Control | 6.24E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC43A1 in colon adenocarcinoma | [ 4 ] | |||
Location |
TSS1500 (cg09432234) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.23E+00 | Statistic Test | p-value:1.26E-03; Z-score:-1.01E+00 | ||
Methylation in Case |
1.20E-01 (Median) | Methylation in Control | 1.47E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC43A1 in colon adenocarcinoma | [ 4 ] | |||
Location |
TSS200 (cg13188098) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.24E+00 | Statistic Test | p-value:1.72E-05; Z-score:1.88E+00 | ||
Methylation in Case |
4.21E-01 (Median) | Methylation in Control | 3.39E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC43A1 in colon adenocarcinoma | [ 4 ] | |||
Location |
Body (cg27648056) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.29E+00 | Statistic Test | p-value:3.61E-06; Z-score:-3.11E+00 | ||
Methylation in Case |
5.81E-01 (Median) | Methylation in Control | 7.49E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC43A1 in colon adenocarcinoma | [ 4 ] | |||
Location |
Body (cg00981877) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.43E+00 | Statistic Test | p-value:4.86E-06; Z-score:-1.32E+00 | ||
Methylation in Case |
9.81E-02 (Median) | Methylation in Control | 1.40E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC43A1 in colon adenocarcinoma | [ 4 ] | |||
Location |
Body (cg24131671) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.19E+00 | Statistic Test | p-value:1.51E-05; Z-score:-1.88E+00 | ||
Methylation in Case |
5.70E-01 (Median) | Methylation in Control | 6.79E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC43A1 in colon adenocarcinoma | [ 4 ] | |||
Location |
Body (cg11981631) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.54E+00 | Statistic Test | p-value:2.69E-03; Z-score:1.96E+00 | ||
Methylation in Case |
1.85E-01 (Median) | Methylation in Control | 1.20E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC43A1 in colon adenocarcinoma | [ 4 ] | |||
Location |
Body (cg08225137) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:4.84E-03; Z-score:-1.10E+00 | ||
Methylation in Case |
7.95E-01 (Median) | Methylation in Control | 8.21E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
Methylation of SLC43A1 in colon adenocarcinoma | [ 4 ] | |||
Location |
3'UTR (cg02497486) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.02E+00 | Statistic Test | p-value:1.42E-03; Z-score:8.78E-01 | ||
Methylation in Case |
8.77E-01 (Median) | Methylation in Control | 8.60E-01 (Median) | ||
Studied Phenotype |
Colon cancer[ ICD-11:2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
15 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC43A1 in hepatocellular carcinoma | [ 5 ] | |||
Location |
5'UTR (cg08572535) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.18E+00 | Statistic Test | p-value:2.56E-05; Z-score:-7.27E-01 | ||
Methylation in Case |
7.82E-02 (Median) | Methylation in Control | 9.22E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC43A1 in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg17363443) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.10E+00 | Statistic Test | p-value:6.73E-03; Z-score:-6.60E-01 | ||
Methylation in Case |
7.61E-02 (Median) | Methylation in Control | 8.40E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC43A1 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg17958577) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.30E+00 | Statistic Test | p-value:3.91E-13; Z-score:-3.77E+00 | ||
Methylation in Case |
5.78E-01 (Median) | Methylation in Control | 7.51E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC43A1 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg09478995) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.34E+00 | Statistic Test | p-value:3.57E-09; Z-score:-1.72E+00 | ||
Methylation in Case |
4.44E-01 (Median) | Methylation in Control | 5.96E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC43A1 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg04431596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.37E+00 | Statistic Test | p-value:2.27E-08; Z-score:-1.45E+00 | ||
Methylation in Case |
3.73E-01 (Median) | Methylation in Control | 5.12E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC43A1 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg17330838) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.25E+00 | Statistic Test | p-value:2.58E-06; Z-score:-1.12E+00 | ||
Methylation in Case |
3.29E-01 (Median) | Methylation in Control | 4.10E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC43A1 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg10964211) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.02E+00 | Statistic Test | p-value:4.08E-06; Z-score:6.40E-01 | ||
Methylation in Case |
8.19E-01 (Median) | Methylation in Control | 8.00E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC43A1 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg26418434) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.39E+00 | Statistic Test | p-value:6.27E-06; Z-score:-1.02E+00 | ||
Methylation in Case |
2.48E-01 (Median) | Methylation in Control | 3.44E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC43A1 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg00089550) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.21E+00 | Statistic Test | p-value:7.55E-06; Z-score:-9.20E-01 | ||
Methylation in Case |
2.93E-01 (Median) | Methylation in Control | 3.55E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC43A1 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg02680086) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.61E+00 | Statistic Test | p-value:8.86E-06; Z-score:-1.21E+00 | ||
Methylation in Case |
1.64E-01 (Median) | Methylation in Control | 2.63E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC43A1 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg23075364) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.47E+00 | Statistic Test | p-value:2.35E-05; Z-score:-1.03E+00 | ||
Methylation in Case |
1.88E-01 (Median) | Methylation in Control | 2.77E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC43A1 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg25284762) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.19E+00 | Statistic Test | p-value:6.64E-05; Z-score:-1.16E+00 | ||
Methylation in Case |
3.56E-01 (Median) | Methylation in Control | 4.22E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
Methylation of SLC43A1 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg27315497) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.19E+00 | Statistic Test | p-value:1.44E-03; Z-score:-9.57E-01 | ||
Methylation in Case |
3.61E-01 (Median) | Methylation in Control | 4.31E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon14 |
Methylation of SLC43A1 in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg17559156) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.27E+00 | Statistic Test | p-value:1.72E-02; Z-score:-1.17E+00 | ||
Methylation in Case |
4.42E-01 (Median) | Methylation in Control | 5.60E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon15 |
Methylation of SLC43A1 in hepatocellular carcinoma | [ 5 ] | |||
Location |
3'UTR (cg19991086) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.29E+00 | Statistic Test | p-value:6.46E-12; Z-score:-2.77E+00 | ||
Methylation in Case |
5.47E-01 (Median) | Methylation in Control | 7.03E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma[ ICD-11:2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC43A1 in HIV infection | [ 6 ] | |||
Location |
5'UTR (cg08572535) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.33E+00 | Statistic Test | p-value:5.27E-05; Z-score:1.44E+00 | ||
Methylation in Case |
1.25E-01 (Median) | Methylation in Control | 9.37E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC43A1 in HIV infection | [ 6 ] | |||
Location |
TSS1500 (cg05375277) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.57E+00 | Statistic Test | p-value:2.87E-03; Z-score:9.41E-01 | ||
Methylation in Case |
1.16E-02 (Median) | Methylation in Control | 7.34E-03 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC43A1 in HIV infection | [ 6 ] | |||
Location |
TSS200 (cg02037518) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.90E+00 | Statistic Test | p-value:1.22E-02; Z-score:9.27E-01 | ||
Methylation in Case |
9.08E-03 (Median) | Methylation in Control | 4.79E-03 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC43A1 in HIV infection | [ 6 ] | |||
Location |
TSS200 (cg17057783) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.20E+00 | Statistic Test | p-value:3.54E-02; Z-score:7.25E-01 | ||
Methylation in Case |
4.05E-02 (Median) | Methylation in Control | 3.39E-02 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC43A1 in HIV infection | [ 6 ] | |||
Location |
Body (cg27315497) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.43E+00 | Statistic Test | p-value:6.73E-14; Z-score:4.77E+00 | ||
Methylation in Case |
7.09E-01 (Median) | Methylation in Control | 4.97E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC43A1 in HIV infection | [ 6 ] | |||
Location |
Body (cg25284762) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:2.71E-11; Z-score:1.56E+00 | ||
Methylation in Case |
8.82E-01 (Median) | Methylation in Control | 8.36E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC43A1 in HIV infection | [ 6 ] | |||
Location |
Body (cg11376147) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.45E+00 | Statistic Test | p-value:1.78E-07; Z-score:2.53E+00 | ||
Methylation in Case |
2.39E-01 (Median) | Methylation in Control | 1.64E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC43A1 in HIV infection | [ 6 ] | |||
Location |
Body (cg23075364) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.22E+00 | Statistic Test | p-value:7.04E-07; Z-score:1.61E+00 | ||
Methylation in Case |
6.35E-01 (Median) | Methylation in Control | 5.20E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC43A1 in HIV infection | [ 6 ] | |||
Location |
Body (cg17330838) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:9.09E-06; Z-score:1.23E+00 | ||
Methylation in Case |
5.96E-01 (Median) | Methylation in Control | 5.55E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC43A1 in HIV infection | [ 6 ] | |||
Location |
Body (cg26418434) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.14E+00 | Statistic Test | p-value:9.45E-06; Z-score:1.40E+00 | ||
Methylation in Case |
5.57E-01 (Median) | Methylation in Control | 4.88E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC43A1 in HIV infection | [ 6 ] | |||
Location |
Body (cg02680086) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.19E+00 | Statistic Test | p-value:4.28E-05; Z-score:1.31E+00 | ||
Methylation in Case |
5.83E-01 (Median) | Methylation in Control | 4.92E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC43A1 in HIV infection | [ 6 ] | |||
Location |
Body (cg00089550) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:2.64E-03; Z-score:7.05E-01 | ||
Methylation in Case |
5.08E-01 (Median) | Methylation in Control | 4.73E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
Methylation of SLC43A1 in HIV infection | [ 6 ] | |||
Location |
3'UTR (cg09888840) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.56E+00 | Statistic Test | p-value:4.30E-10; Z-score:3.11E+00 | ||
Methylation in Case |
6.91E-01 (Median) | Methylation in Control | 4.42E-01 (Median) | ||
Studied Phenotype |
HIV infection[ ICD-11:1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC43A1 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
5'UTR (cg11207893) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:3.20E-07; Z-score:-1.06E+00 | ||
Methylation in Case |
9.00E-01 (Median) | Methylation in Control | 9.14E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC43A1 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
5'UTR (cg16405055) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.02E+00 | Statistic Test | p-value:3.37E-02; Z-score:-6.62E-02 | ||
Methylation in Case |
3.84E-02 (Median) | Methylation in Control | 3.91E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC43A1 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg01826863) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.74E+00 | Statistic Test | p-value:8.98E-22; Z-score:5.90E+00 | ||
Methylation in Case |
3.73E-01 (Median) | Methylation in Control | 2.15E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC43A1 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg15828524) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:8.16E-05; Z-score:1.07E+00 | ||
Methylation in Case |
8.65E-01 (Median) | Methylation in Control | 8.27E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC43A1 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg19777783) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:4.22E-02; Z-score:-7.80E-01 | ||
Methylation in Case |
6.11E-01 (Median) | Methylation in Control | 6.48E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC43A1 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS200 (cg09210286) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.39E+00 | Statistic Test | p-value:1.93E-15; Z-score:3.07E+00 | ||
Methylation in Case |
9.01E-02 (Median) | Methylation in Control | 6.48E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC43A1 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg13044838) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:1.79E-09; Z-score:1.89E+00 | ||
Methylation in Case |
8.46E-01 (Median) | Methylation in Control | 7.73E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC43A1 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg20422819) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.10E+00 | Statistic Test | p-value:6.55E-06; Z-score:1.50E+00 | ||
Methylation in Case |
7.17E-01 (Median) | Methylation in Control | 6.54E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC43A1 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg20244340) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.18E+00 | Statistic Test | p-value:5.98E-03; Z-score:-1.10E+00 | ||
Methylation in Case |
2.53E-01 (Median) | Methylation in Control | 2.98E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC43A1 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg26572770) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.03E+00 | Statistic Test | p-value:6.20E-03; Z-score:-3.38E-01 | ||
Methylation in Case |
7.33E-01 (Median) | Methylation in Control | 7.58E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC43A1 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg25213968) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.06E+00 | Statistic Test | p-value:1.42E-02; Z-score:-5.69E-01 | ||
Methylation in Case |
7.02E-01 (Median) | Methylation in Control | 7.45E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC43A1 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg20869999) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.01E+00 | Statistic Test | p-value:3.53E-02; Z-score:2.28E-01 | ||
Methylation in Case |
5.88E-01 (Median) | Methylation in Control | 5.83E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon13 |
Methylation of SLC43A1 in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
3'UTR (cg12468553) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.02E+00 | Statistic Test | p-value:3.44E-02; Z-score:2.83E-01 | ||
Methylation in Case |
8.20E-01 (Median) | Methylation in Control | 8.02E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma[ ICD-11:2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
12 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC43A1 in colorectal cancer | [ 8 ] | |||
Location |
TSS1500 (cg26624118) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.08E+00 | Statistic Test | p-value:3.29E-03; Z-score:7.02E-01 | ||
Methylation in Case |
1.01E-01 (Median) | Methylation in Control | 9.30E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC43A1 in colorectal cancer | [ 8 ] | |||
Location |
TSS200 (cg23409370) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.34E+00 | Statistic Test | p-value:4.00E-05; Z-score:-1.16E+00 | ||
Methylation in Case |
1.05E-01 (Median) | Methylation in Control | 1.41E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC43A1 in colorectal cancer | [ 8 ] | |||
Location |
TSS200 (cg14028489) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.21E+00 | Statistic Test | p-value:4.87E-03; Z-score:7.29E-01 | ||
Methylation in Case |
1.01E-02 (Median) | Methylation in Control | 8.31E-03 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC43A1 in colorectal cancer | [ 8 ] | |||
Location |
TSS200 (cg17057783) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.11E+00 | Statistic Test | p-value:1.81E-02; Z-score:-3.18E-01 | ||
Methylation in Case |
3.08E-02 (Median) | Methylation in Control | 3.43E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC43A1 in colorectal cancer | [ 8 ] | |||
Location |
Body (cg00089550) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.28E+00 | Statistic Test | p-value:6.68E-04; Z-score:1.20E+00 | ||
Methylation in Case |
4.71E-01 (Median) | Methylation in Control | 3.68E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC43A1 in colorectal cancer | [ 8 ] | |||
Location |
Body (cg11376147) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.18E+00 | Statistic Test | p-value:1.49E-03; Z-score:-1.36E+00 | ||
Methylation in Case |
2.91E-01 (Median) | Methylation in Control | 3.45E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC43A1 in colorectal cancer | [ 8 ] | |||
Location |
Body (cg26418434) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.35E+00 | Statistic Test | p-value:1.92E-03; Z-score:8.18E-01 | ||
Methylation in Case |
2.29E-01 (Median) | Methylation in Control | 1.69E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC43A1 in colorectal cancer | [ 8 ] | |||
Location |
Body (cg17330838) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.29E+00 | Statistic Test | p-value:2.04E-03; Z-score:1.06E+00 | ||
Methylation in Case |
3.33E-01 (Median) | Methylation in Control | 2.59E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC43A1 in colorectal cancer | [ 8 ] | |||
Location |
Body (cg02680086) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.32E+00 | Statistic Test | p-value:2.17E-03; Z-score:8.13E-01 | ||
Methylation in Case |
1.88E-01 (Median) | Methylation in Control | 1.42E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC43A1 in colorectal cancer | [ 8 ] | |||
Location |
Body (cg27315497) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.20E+00 | Statistic Test | p-value:3.75E-03; Z-score:8.32E-01 | ||
Methylation in Case |
3.98E-01 (Median) | Methylation in Control | 3.33E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC43A1 in colorectal cancer | [ 8 ] | |||
Location |
Body (cg23075364) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.18E+00 | Statistic Test | p-value:7.70E-03; Z-score:6.39E-01 | ||
Methylation in Case |
4.25E-01 (Median) | Methylation in Control | 3.60E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon12 |
Methylation of SLC43A1 in colorectal cancer | [ 8 ] | |||
Location |
Body (cg12619347) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:1.86E-02; Z-score:-9.69E-01 | ||
Methylation in Case |
7.46E-01 (Median) | Methylation in Control | 7.79E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer[ ICD-11:2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
10 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC43A1 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS1500 (cg26624118) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.10E+00 | Statistic Test | p-value:1.60E-03; Z-score:-6.78E-01 | ||
Methylation in Case |
6.80E-02 (Median) | Methylation in Control | 7.46E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC43A1 in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS200 (cg23409370) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.14E+00 | Statistic Test | p-value:5.89E-03; Z-score:-6.41E-01 | ||
Methylation in Case |
5.68E-02 (Median) | Methylation in Control | 6.48E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC43A1 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg10964211) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:2.52E-10; Z-score:-2.12E+00 | ||
Methylation in Case |
8.51E-01 (Median) | Methylation in Control | 8.95E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC43A1 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg09478995) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.28E+00 | Statistic Test | p-value:1.34E-07; Z-score:1.49E+00 | ||
Methylation in Case |
5.49E-01 (Median) | Methylation in Control | 4.28E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC43A1 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg25284762) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.06E+00 | Statistic Test | p-value:5.37E-05; Z-score:5.91E-01 | ||
Methylation in Case |
5.36E-01 (Median) | Methylation in Control | 5.03E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC43A1 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg27315497) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.07E+00 | Statistic Test | p-value:8.49E-05; Z-score:1.13E+00 | ||
Methylation in Case |
7.65E-01 (Median) | Methylation in Control | 7.18E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC43A1 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg04431596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.01E+00 | Statistic Test | p-value:2.59E-03; Z-score:-6.98E-01 | ||
Methylation in Case |
9.47E-01 (Median) | Methylation in Control | 9.54E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC43A1 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg17330838) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.24E+00 | Statistic Test | p-value:3.65E-02; Z-score:6.62E-01 | ||
Methylation in Case |
2.65E-01 (Median) | Methylation in Control | 2.13E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC43A1 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg26418434) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.34E+00 | Statistic Test | p-value:3.78E-02; Z-score:6.10E-01 | ||
Methylation in Case |
1.91E-01 (Median) | Methylation in Control | 1.42E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC43A1 in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg11376147) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:4.29E-02; Z-score:-5.41E-01 | ||
Methylation in Case |
1.88E-01 (Median) | Methylation in Control | 1.97E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer[ ICD-11:2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC43A1 in prostate cancer | [ 10 ] | |||
Location |
TSS1500 (cg20408693) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:5.63E+00 | Statistic Test | p-value:2.40E-03; Z-score:2.79E+01 | ||
Methylation in Case |
5.36E-01 (Median) | Methylation in Control | 9.52E-02 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC43A1 in prostate cancer | [ 10 ] | |||
Location |
TSS200 (cg19766441) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:6.64E+00 | Statistic Test | p-value:3.25E-03; Z-score:1.38E+01 | ||
Methylation in Case |
5.37E-01 (Median) | Methylation in Control | 8.09E-02 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC43A1 in prostate cancer | [ 10 ] | |||
Location |
TSS200 (cg23365801) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.72E+00 | Statistic Test | p-value:8.34E-03; Z-score:2.69E+00 | ||
Methylation in Case |
6.38E-01 (Median) | Methylation in Control | 3.71E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC43A1 in prostate cancer | [ 10 ] | |||
Location |
Body (cg10423743) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:4.92E-04; Z-score:4.48E+00 | ||
Methylation in Case |
9.52E-01 (Median) | Methylation in Control | 9.04E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC43A1 in prostate cancer | [ 10 ] | |||
Location |
Body (cg09478995) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.57E+00 | Statistic Test | p-value:3.63E-03; Z-score:-4.03E+00 | ||
Methylation in Case |
4.91E-01 (Median) | Methylation in Control | 7.70E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC43A1 in prostate cancer | [ 10 ] | |||
Location |
Body (cg09565111) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.33E+00 | Statistic Test | p-value:4.07E-03; Z-score:-4.09E+00 | ||
Methylation in Case |
4.53E-01 (Median) | Methylation in Control | 6.03E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC43A1 in prostate cancer | [ 10 ] | |||
Location |
Body (cg24738346) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.18E+00 | Statistic Test | p-value:4.55E-03; Z-score:3.09E+00 | ||
Methylation in Case |
7.30E-01 (Median) | Methylation in Control | 3.35E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC43A1 in prostate cancer | [ 10 ] | |||
Location |
Body (cg02902412) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.09E+00 | Statistic Test | p-value:5.73E-03; Z-score:3.23E+00 | ||
Methylation in Case |
9.40E-01 (Median) | Methylation in Control | 8.66E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC43A1 in prostate cancer | [ 10 ] | |||
Location |
Body (cg16296843) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.28E+00 | Statistic Test | p-value:1.97E-02; Z-score:-3.96E+00 | ||
Methylation in Case |
4.37E-01 (Median) | Methylation in Control | 5.62E-01 (Median) | ||
Studied Phenotype |
Prostate cancer[ ICD-11:2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC43A1 in systemic lupus erythematosus | [ 11 ] | |||
Location |
TSS1500 (cg05375277) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.05E+00 | Statistic Test | p-value:2.22E-02; Z-score:1.30E-01 | ||
Methylation in Case |
1.32E-02 (Median) | Methylation in Control | 1.26E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC43A1 in systemic lupus erythematosus | [ 11 ] | |||
Location |
TSS200 (cg18004239) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:4.98E-02; Z-score:1.44E-01 | ||
Methylation in Case |
5.35E-02 (Median) | Methylation in Control | 5.18E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC43A1 in systemic lupus erythematosus | [ 11 ] | |||
Location |
Body (cg11376147) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.09E+00 | Statistic Test | p-value:2.99E-03; Z-score:-3.30E-01 | ||
Methylation in Case |
2.73E-01 (Median) | Methylation in Control | 2.99E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC43A1 in systemic lupus erythematosus | [ 11 ] | |||
Location |
Body (cg10964211) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.03E+00 | Statistic Test | p-value:1.58E-02; Z-score:2.10E-01 | ||
Methylation in Case |
8.03E-01 (Median) | Methylation in Control | 7.81E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC43A1 in systemic lupus erythematosus | [ 11 ] | |||
Location |
Body (cg25284762) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.00E+00 | Statistic Test | p-value:3.29E-02; Z-score:-1.84E-01 | ||
Methylation in Case |
9.03E-01 (Median) | Methylation in Control | 9.07E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC43A1 in systemic lupus erythematosus | [ 11 ] | |||
Location |
Body (cg00089550) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:3.87E-02; Z-score:-3.10E-01 | ||
Methylation in Case |
5.66E-01 (Median) | Methylation in Control | 5.86E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus[ ICD-11:4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
11 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC43A1 in bladder cancer | [ 12 ] | |||
Location |
Body (cg11376147) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.72E+00 | Statistic Test | p-value:2.74E-12; Z-score:-1.15E+01 | ||
Methylation in Case |
1.66E-01 (Median) | Methylation in Control | 2.85E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC43A1 in bladder cancer | [ 12 ] | |||
Location |
Body (cg27315497) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.33E+00 | Statistic Test | p-value:1.52E-06; Z-score:4.54E+00 | ||
Methylation in Case |
6.37E-01 (Median) | Methylation in Control | 4.79E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC43A1 in bladder cancer | [ 12 ] | |||
Location |
Body (cg04431596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.42E+00 | Statistic Test | p-value:3.52E-06; Z-score:-2.70E+01 | ||
Methylation in Case |
6.39E-01 (Median) | Methylation in Control | 9.05E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC43A1 in bladder cancer | [ 12 ] | |||
Location |
Body (cg12619347) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.53E+00 | Statistic Test | p-value:3.62E-06; Z-score:-4.01E+00 | ||
Methylation in Case |
3.56E-01 (Median) | Methylation in Control | 5.46E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC43A1 in bladder cancer | [ 12 ] | |||
Location |
Body (cg17559156) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.39E+00 | Statistic Test | p-value:9.22E-04; Z-score:-2.74E+00 | ||
Methylation in Case |
5.14E-01 (Median) | Methylation in Control | 7.12E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC43A1 in bladder cancer | [ 12 ] | |||
Location |
Body (cg24733435) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.04E+00 | Statistic Test | p-value:2.59E-03; Z-score:-1.65E+00 | ||
Methylation in Case |
7.32E-01 (Median) | Methylation in Control | 7.64E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon7 |
Methylation of SLC43A1 in bladder cancer | [ 12 ] | |||
Location |
Body (cg17330838) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.15E+00 | Statistic Test | p-value:6.05E-03; Z-score:-2.12E+00 | ||
Methylation in Case |
3.28E-01 (Median) | Methylation in Control | 3.78E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon8 |
Methylation of SLC43A1 in bladder cancer | [ 12 ] | |||
Location |
Body (cg10964211) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.05E+00 | Statistic Test | p-value:7.32E-03; Z-score:-2.32E+00 | ||
Methylation in Case |
7.58E-01 (Median) | Methylation in Control | 7.93E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon9 |
Methylation of SLC43A1 in bladder cancer | [ 12 ] | |||
Location |
Body (cg26418434) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.35E+00 | Statistic Test | p-value:8.42E-03; Z-score:-1.82E+00 | ||
Methylation in Case |
2.43E-01 (Median) | Methylation in Control | 3.29E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon10 |
Methylation of SLC43A1 in bladder cancer | [ 12 ] | |||
Location |
Body (cg00089550) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.07E+00 | Statistic Test | p-value:4.73E-02; Z-score:-6.56E-01 | ||
Methylation in Case |
2.97E-01 (Median) | Methylation in Control | 3.17E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon11 |
Methylation of SLC43A1 in bladder cancer | [ 12 ] | |||
Location |
Body (cg02680086) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.64E+00 | Statistic Test | p-value:4.90E-02; Z-score:-1.85E+00 | ||
Methylation in Case |
1.42E-01 (Median) | Methylation in Control | 2.33E-01 (Median) | ||
Studied Phenotype |
Bladder cancer[ ICD-11:2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Celiac disease |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC43A1 in celiac disease | [ 13 ] | |||
Location |
Body (cg04431596) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:2.50E+00 | Statistic Test | p-value:4.74E-02; Z-score:1.27E+00 | ||
Methylation in Case |
5.83E-01 (Median) | Methylation in Control | 2.33E-01 (Median) | ||
Studied Phenotype |
Celiac disease[ ICD-11:DA95] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC43A1 in lung adenocarcinoma | [ 14 ] | |||
Location |
Body (cg23075364) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.72E+00 | Statistic Test | p-value:2.62E-04; Z-score:3.86E+00 | ||
Methylation in Case |
5.63E-01 (Median) | Methylation in Control | 3.28E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC43A1 in lung adenocarcinoma | [ 14 ] | |||
Location |
Body (cg17330838) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.27E+00 | Statistic Test | p-value:2.82E-04; Z-score:2.81E+00 | ||
Methylation in Case |
5.87E-01 (Median) | Methylation in Control | 4.64E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC43A1 in lung adenocarcinoma | [ 14 ] | |||
Location |
Body (cg26418434) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.33E+00 | Statistic Test | p-value:3.38E-04; Z-score:2.48E+00 | ||
Methylation in Case |
5.44E-01 (Median) | Methylation in Control | 4.08E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon4 |
Methylation of SLC43A1 in lung adenocarcinoma | [ 14 ] | |||
Location |
Body (cg02680086) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.63E+00 | Statistic Test | p-value:7.34E-04; Z-score:4.59E+00 | ||
Methylation in Case |
5.10E-01 (Median) | Methylation in Control | 3.13E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon5 |
Methylation of SLC43A1 in lung adenocarcinoma | [ 14 ] | |||
Location |
Body (cg00089550) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.13E+00 | Statistic Test | p-value:1.93E-02; Z-score:1.31E+00 | ||
Methylation in Case |
5.00E-01 (Median) | Methylation in Control | 4.41E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon6 |
Methylation of SLC43A1 in lung adenocarcinoma | [ 14 ] | |||
Location |
Body (cg25284762) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.20E+00 | Statistic Test | p-value:2.73E-02; Z-score:2.62E+00 | ||
Methylation in Case |
6.30E-01 (Median) | Methylation in Control | 5.23E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma[ ICD-11:2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
Methylation of SLC43A1 in panic disorder | [ 15 ] | |||
Location |
Body (cg17330838) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:1.27E+01 | Statistic Test | p-value:5.15E-03; Z-score:-4.82E-01 | ||
Methylation in Case |
-6.35E-03 (Median) | Methylation in Control | 8.04E-02 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon2 |
Methylation of SLC43A1 in panic disorder | [ 15 ] | |||
Location |
Body (cg27315497) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-1.39E-01 | Statistic Test | p-value:1.55E-02; Z-score:-4.15E-01 | ||
Methylation in Case |
-1.75E-01 (Median) | Methylation in Control | -2.43E-02 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon3 |
Methylation of SLC43A1 in panic disorder | [ 15 ] | |||
Location |
3'UTR (cg09888840) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change:-7.73E-01 | Statistic Test | p-value:1.83E-02; Z-score:-3.33E-01 | ||
Methylation in Case |
-1.00E+00 (Median) | Methylation in Control | -7.74E-01 (Median) | ||
Studied Phenotype |
Panic disorder[ ICD-11:6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
Unclear Phenotype |
17 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon1 |
miR-1226 directly targets SLC43A1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-1226 | miRNA Mature ID | miR-1226-3p | ||
miRNA Sequence |
UCACCAGCCCUGUGUUCCCUAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon2 |
miR-1238 directly targets SLC43A1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-1238 | miRNA Mature ID | miR-1238-3p | ||
miRNA Sequence |
CUUCCUCGUCUGUCUGCCCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon3 |
miR-1304 directly targets SLC43A1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-1304 | miRNA Mature ID | miR-1304-3p | ||
miRNA Sequence |
UCUCACUGUAGCCUCGAACCCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon4 |
miR-204 directly targets SLC43A1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-204 | miRNA Mature ID | miR-204-5p | ||
miRNA Sequence |
UUCCCUUUGUCAUCCUAUGCCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon5 |
miR-211 directly targets SLC43A1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-211 | miRNA Mature ID | miR-211-5p | ||
miRNA Sequence |
UUCCCUUUGUCAUCCUUCGCCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon6 |
miR-27b directly targets SLC43A1 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-27b | miRNA Mature ID | miR-27b-3p | ||
miRNA Sequence |
UUCACAGUGGCUAAGUUCUGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon7 |
miR-4676 directly targets SLC43A1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4676 | miRNA Mature ID | miR-4676-5p | ||
miRNA Sequence |
GAGCCAGUGGUGAGACAGUGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon8 |
miR-4755 directly targets SLC43A1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4755 | miRNA Mature ID | miR-4755-5p | ||
miRNA Sequence |
UUUCCCUUCAGAGCCUGGCUUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon9 |
miR-484 directly targets SLC43A1 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | CLASH | ||
miRNA Stemloop ID |
miR-484 | miRNA Mature ID | miR-484 | ||
miRNA Sequence |
UCAGGCUCAGUCCCCUCCCGAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon10 |
miR-5006 directly targets SLC43A1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-5006 | miRNA Mature ID | miR-5006-3p | ||
miRNA Sequence |
UUUCCCUUUCCAUCCUGGCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon11 |
miR-521 directly targets SLC43A1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-521 | miRNA Mature ID | miR-521 | ||
miRNA Sequence |
AACGCACUUCCCUUUAGAGUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon12 |
miR-575 directly targets SLC43A1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-575 | miRNA Mature ID | miR-575 | ||
miRNA Sequence |
GAGCCAGUUGGACAGGAGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon13 |
miR-623 directly targets SLC43A1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-623 | miRNA Mature ID | miR-623 | ||
miRNA Sequence |
AUCCCUUGCAGGGGCUGUUGGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon14 |
miR-670 directly targets SLC43A1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-670 | miRNA Mature ID | miR-670-3p | ||
miRNA Sequence |
UUUCCUCAUAUUCAUUCAGGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon15 |
miR-6832 directly targets SLC43A1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6832 | miRNA Mature ID | miR-6832-3p | ||
miRNA Sequence |
ACCCUUUUUCUCUUUCCCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon16 |
miR-6881 directly targets SLC43A1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6881 | miRNA Mature ID | miR-6881-3p | ||
miRNA Sequence |
AUCCUCUUUCGUCCUUCCCACU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon17 |
miR-7111 directly targets SLC43A1 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-7111 | miRNA Mature ID | miR-7111-3p | ||
miRNA Sequence |
AUCCUCUCUUCCCUCCUCCCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.